LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 157

Search options

  1. Article ; Online: Old vaccines, new diseases: when BCG meets SPPL2a.

    Rosenzweig, Sergio D

    Nature immunology

    2018  Volume 19, Issue 9, Page(s) 906–907

    MeSH term(s) Aspartic Acid Endopeptidases ; Histocompatibility Antigens Class II ; Humans ; T-Lymphocytes, Helper-Inducer ; Vaccines
    Chemical Substances Histocompatibility Antigens Class II ; Vaccines ; Aspartic Acid Endopeptidases (EC 3.4.23.-) ; SPPL2a protein, human (EC 3.4.23.-)
    Language English
    Publishing date 2018-08-13
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Comment
    ZDB-ID 2016987-5
    ISSN 1529-2916 ; 1529-2908
    ISSN (online) 1529-2916
    ISSN 1529-2908
    DOI 10.1038/s41590-018-0193-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Inborn errors of human IKAROS: LOF and GOF variants associated with primary immunodeficiency.

    Kuehn, Hye Sun / Boast, Brigette / Rosenzweig, Sergio D

    Clinical and experimental immunology

    2022  Volume 212, Issue 2, Page(s) 129–136

    Abstract: IKAROS/IKZF1 plays a pivotal role in lymphocyte differentiation and development. Germline mutations in IKZF1, which have been shown to be associated with primary immunodeficiency, can be classified through four different mechanisms of action depending on ...

    Abstract IKAROS/IKZF1 plays a pivotal role in lymphocyte differentiation and development. Germline mutations in IKZF1, which have been shown to be associated with primary immunodeficiency, can be classified through four different mechanisms of action depending on the protein expression and its functional defects: haploinsufficiency, dimerization defective, dominant negative, and gain of function. These different mechanisms are associated with variable degrees of susceptibility to infectious diseases, autoimmune disorders, allergic diseases, and malignancies. To date, more than 30 heterozygous IKZF1 germline variants have been reported in patients with primary immunodeficiency. Here we review recent discoveries and clinical/immunological characterization of IKAROS-associated diseases that are linked to different mechanisms of action in IKAROS function.
    MeSH term(s) Humans ; Autoimmune Diseases ; Ikaros Transcription Factor/genetics ; Ikaros Transcription Factor/metabolism ; Neoplasms ; Transcription Factors
    Chemical Substances Ikaros Transcription Factor (148971-36-2) ; Transcription Factors
    Language English
    Publishing date 2022-11-25
    Publishing country England
    Document type Review ; Journal Article
    ZDB-ID 218531-3
    ISSN 1365-2249 ; 0009-9104 ; 0964-2536
    ISSN (online) 1365-2249
    ISSN 0009-9104 ; 0964-2536
    DOI 10.1093/cei/uxac109
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Lymphocyte reference intervals in the era of newborn screening.

    Fleisher, Thomas A / Rosenzweig, Sergio D

    The Journal of allergy and clinical immunology

    2019  Volume 144, Issue 6, Page(s) 1516–1517

    MeSH term(s) Humans ; Infant, Newborn ; Lymphocyte Count ; Lymphocyte Subsets ; Neonatal Screening ; Reference Values
    Language English
    Publishing date 2019-10-07
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Intramural ; Comment
    ZDB-ID 121011-7
    ISSN 1097-6825 ; 1085-8725 ; 0091-6749
    ISSN (online) 1097-6825 ; 1085-8725
    ISSN 0091-6749
    DOI 10.1016/j.jaci.2019.09.022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: News from the CIS Executive Committee.

    Rosenzweig, Sergio D

    Journal of clinical immunology

    2014  Volume 34, Issue 2, Page(s) 129

    MeSH term(s) Humans ; Periodicals as Topic
    Language English
    Publishing date 2014-02
    Publishing country Netherlands
    Document type Editorial ; News
    ZDB-ID 779361-3
    ISSN 1573-2592 ; 0271-9142
    ISSN (online) 1573-2592
    ISSN 0271-9142
    DOI 10.1007/s10875-013-9984-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Germline

    Kuehn, Hye Sun / Nunes-Santos, Cristiane J / Rosenzweig, Sergio D

    Expert review of clinical immunology

    2021  Volume 17, Issue 4, Page(s) 407–416

    Abstract: ... ...

    Abstract Introduction
    MeSH term(s) Genetic Association Studies ; Germ Cells ; Germ-Line Mutation ; Humans ; Ikaros Transcription Factor/genetics ; Immunity/genetics ; Phenotype
    Chemical Substances IKZF1 protein, human ; Ikaros Transcription Factor (148971-36-2)
    Language English
    Publishing date 2021-03-19
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Review
    ZDB-ID 2274260-8
    ISSN 1744-8409 ; 1744-666X
    ISSN (online) 1744-8409
    ISSN 1744-666X
    DOI 10.1080/1744666X.2021.1901582
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity.

    Kuehn, Hye Sun / Nunes-Santos, Cristiane J / Rosenzweig, Sergio D

    Journal of clinical immunology

    2021  Volume 41, Issue 1, Page(s) 1–10

    Abstract: IKAROS, encoded by IKZF1, is a zinc finger transcription factor and a critical regulator of hematopoiesis. Mutations in IKZF1 have been implicated in immune deficiency, autoimmunity, and malignancy in humans. Somatic IKZF1 loss-of-function mutations and ... ...

    Abstract IKAROS, encoded by IKZF1, is a zinc finger transcription factor and a critical regulator of hematopoiesis. Mutations in IKZF1 have been implicated in immune deficiency, autoimmunity, and malignancy in humans. Somatic IKZF1 loss-of-function mutations and deletions have been shown to increase predisposition to the development of B cell acute lymphoblastic leukemia (B-ALL) and associated with poor prognosis. In the last 4 years, germline heterozygous IKZF1 mutations have been reported in primary immune deficiency/inborn errors of immunity. These allelic variants, acting by either haploinsufficiency or dominant negative mechanisms affecting particular functions of IKAROS, are associated with common variable immunodeficiency, combined immunodeficiency, or primarily hematologic phenotypes in affected patients. In this review, we provide an overview of genetic, clinical, and immunological manifestations in patients with IKZF1 mutations, and the molecular and cellular mechanisms that contribute to their disease as a consequence of IKAROS dysfunction.
    MeSH term(s) Alleles ; Diagnosis, Differential ; Genetic Association Studies/methods ; Genetic Diseases, Inborn ; Genetic Predisposition to Disease ; Genetic Variation ; Genotype ; Germ-Line Mutation ; Haploinsufficiency ; Humans ; Ikaros Transcription Factor/genetics ; Ikaros Transcription Factor/metabolism ; Mutation ; Penetrance ; Phenotype ; Primary Immunodeficiency Diseases/diagnosis ; Primary Immunodeficiency Diseases/etiology ; Prognosis ; Protein Binding ; Protein Interaction Domains and Motifs/genetics ; Protein Multimerization
    Chemical Substances Ikaros Transcription Factor (148971-36-2)
    Language English
    Publishing date 2021-01-03
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Review
    ZDB-ID 779361-3
    ISSN 1573-2592 ; 0271-9142
    ISSN (online) 1573-2592
    ISSN 0271-9142
    DOI 10.1007/s10875-020-00936-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: An update on gain-of-function mutations in primary immunodeficiency diseases.

    Jhamnani, Rekha D / Rosenzweig, Sergio D

    Current opinion in allergy and clinical immunology

    2017  Volume 17, Issue 6, Page(s) 391–397

    Abstract: Purpose of review: Most primary immunodeficiencies described since 1952 were associated with loss-of-function defects. With the advent and popularization of unbiased next-generation sequencing diagnostic approaches followed by functional validation ... ...

    Abstract Purpose of review: Most primary immunodeficiencies described since 1952 were associated with loss-of-function defects. With the advent and popularization of unbiased next-generation sequencing diagnostic approaches followed by functional validation techniques, many gain-of-function mutations leading to immunodeficiency have also been identified. This review highlights the updates on pathophysiology mechanisms and new therapeutic approaches involving primary immunodeficiencies because of gain-of-function mutations.
    Recent findings: The more recent developments related to gain-of-function primary immunodeficiencies mostly involving increased infection susceptibility but also immune dysregulation and autoimmunity, were reviewed. Updates regarding pathophysiology mechanisms, different mutation types, clinical features, laboratory markers, current and potential new treatments on patients with caspase recruitment domain family member 11, signal transducer and activator of transcription 1, signal transducer and activator of transcription 3, phosphatidylinositol-4,5-biphosphate 3-kinase catalytic 110, phosphatidylinositol-4,5-biphosphate 3-kinase regulatory subunit 1, chemokine C-X-C motif receptor 4, sterile α motif domain containing 9-like, and nuclear factor κ-B subunit 2 gain-of-function mutations are reviewed for each disease.
    Summary: With the identification of gain-of-function mutations as a cause of immunodeficiency, new genetic pathophysiology mechanisms unveiled and new-targeted therapeutic approaches can be explored as potential rescue treatments for these diseases.
    Language English
    Publishing date 2017-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2088710-3
    ISSN 1473-6322 ; 1528-4050
    ISSN (online) 1473-6322
    ISSN 1528-4050
    DOI 10.1097/ACI.0000000000000401
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: IKAROS gain of function disease: Allogeneic hematopoietic cell transplantation experience and expanded clinical phenotypes.

    Klangkalya, Natchanun / Stoddard, Jennifer / Niemela, Julie / Sponaugle, Jennifer / Greenwell, Irl Brian / Reigh, Erin / Kuehn, Hye Sun / Kanakry, Jennifer A / Rosenzweig, Sergio D / Dimitrova, Dimana

    Clinical immunology (Orlando, Fla.)

    2024  Volume 260, Page(s) 109922

    Abstract: IKAROS, encoded by IKZF1, is a tumor suppressor and a key hematopoietic transcription factor responsible for lymphoid and myeloid differentiation. IKZF1 mutations result in inborn errors of immunity presenting with increased susceptibility to infections, ...

    Abstract IKAROS, encoded by IKZF1, is a tumor suppressor and a key hematopoietic transcription factor responsible for lymphoid and myeloid differentiation. IKZF1 mutations result in inborn errors of immunity presenting with increased susceptibility to infections, immune dysregulation, and malignancies. In particular, patients carrying IKZF1 gain-of-function (GOF) mutations mostly exhibit symptoms of immune dysregulation and polyclonal plasma cell proliferation. Herein, we describe seven new IKAROS GOF cases from two unrelated families, presenting with novel infectious, immune dysregulation and hematologic diseases. Two of the patients underwent allogeneic hematopoietic cell transplantation (HCT) due to poorly responsive complications. HCT was well-tolerated achieving full engraftment in both patients receiving reduced intensity, matched unrelated donor grafts, with no severe acute or chronic graft-vs-host-disease, and in remission from their diseases 2.5 and 4 years post-HCT, respectively. These results suggest that HCT is a valid and curative option in patients with IKAROS GOF disease and severe clinical manifestations.
    MeSH term(s) Humans ; Gain of Function Mutation ; Hematologic Diseases ; Hematopoietic Stem Cell Transplantation ; Transplantation Conditioning/methods ; Ikaros Transcription Factor/genetics
    Chemical Substances IKZF1 protein, human ; Ikaros Transcription Factor (148971-36-2)
    Language English
    Publishing date 2024-02-05
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 1459903-x
    ISSN 1521-7035 ; 1521-6616
    ISSN (online) 1521-7035
    ISSN 1521-6616
    DOI 10.1016/j.clim.2024.109922
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: PI3K pathway defects leading to immunodeficiency and immune dysregulation.

    Nunes-Santos, Cristiane J / Uzel, Gulbu / Rosenzweig, Sergio D

    The Journal of allergy and clinical immunology

    2019  Volume 143, Issue 5, Page(s) 1676–1687

    Abstract: The phosphatidylinositol 3-kinase (PI3K) signaling pathway is involved in a broad range of cellular processes, including growth, metabolism, differentiation, proliferation, motility, and survival. The PI3Kδ enzyme complex is primarily present in the ... ...

    Abstract The phosphatidylinositol 3-kinase (PI3K) signaling pathway is involved in a broad range of cellular processes, including growth, metabolism, differentiation, proliferation, motility, and survival. The PI3Kδ enzyme complex is primarily present in the immune system and comprises a catalytic (p110δ) and regulatory (p85α) subunit. Dynamic regulation of PI3Kδ activity is required to ensure normal function and differentiation of immune cells. In the last decade, discovery of germline mutations in genes involved in the PI3Kδ pathway (PIK3CD, PIK3R1, or phosphatase and tensin homolog [PTEN]) proved that both overactivation and underactivation (gain of function and loss of function, respectively) of PI3Kδ lead to impaired and dysregulated immunity. Although a small group of patients reported to underactivate PI3Kδ show predominantly humoral defects and autoimmune features, more than 200 patients have been described with overactivation of PI3Kδ, presenting with a much more complex phenotype of combined immunodeficiency and immune dysregulation. The clinical and immunologic characterization, as well as current pathophysiologic understanding and specific therapies for PI3K pathway defects leading to immunodeficiency and immune dysregulation, are reviewed here.
    MeSH term(s) Animals ; Autoimmunity ; Cell Differentiation ; Class I Phosphatidylinositol 3-Kinases/genetics ; Class I Phosphatidylinositol 3-Kinases/metabolism ; Humans ; Immune System/physiology ; Immunity, Humoral ; Immunologic Deficiency Syndromes/genetics ; Immunologic Deficiency Syndromes/metabolism ; Mutation/genetics ; Phenotype ; Phosphatidylinositol 3-Kinases/metabolism ; Signal Transduction
    Chemical Substances Class I Phosphatidylinositol 3-Kinases (EC 2.7.1.137) ; PIK3CD protein, human (EC 2.7.1.137)
    Language English
    Publishing date 2019-05-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Review
    ZDB-ID 121011-7
    ISSN 1097-6825 ; 1085-8725 ; 0091-6749
    ISSN (online) 1097-6825 ; 1085-8725
    ISSN 0091-6749
    DOI 10.1016/j.jaci.2019.03.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A novel IKZF1 variant in a family with autosomal dominant CVID: A case for expanding exon coverage in inborn errors of immunity.

    Stojkic, Ivana / Prince, Benjamin T / Kuehn, Hye Sun / Gil Silva, Agustin A / Varga, Elizabeth A / Rosenzweig, Sergio D / Ramadesikan, Swetha / Supinger, Rachel / Marhabaie, Mohammad / Chang, Peter / Mardis, Elaine R / Koboldt, Daniel C

    Clinical immunology (Orlando, Fla.)

    2024  Volume 264, Page(s) 110244

    Abstract: Common variable immune deficiency (CVID) is a heterogenous group of disorders characterized by varying degrees of hypogammaglobulinemia, recurrent infections, and autoimmunity. Currently, pathogenic variants are identified in approximately 20-30% of CVID ...

    Abstract Common variable immune deficiency (CVID) is a heterogenous group of disorders characterized by varying degrees of hypogammaglobulinemia, recurrent infections, and autoimmunity. Currently, pathogenic variants are identified in approximately 20-30% of CVID cases. Here we report a 3-generation family with autosomal dominant Common Variable Immunodeficiency (CVID) diagnosed in 9 affected individuals. Although primary immune deficiency panels and exome sequencing were non-diagnostic, whole genome sequencing revealed a novel, pathogenic c.499C > T: p.His167Tyr variant in IKZF1, a critical regulator of B cell development. Functional testing done through pericentromeric heterochromatin localization and light shift chemiluminescent electrophoretic mobility shift assay confirmed the variant's deleterious effect via a haploinsufficiency mechanism. Our findings expand the spectrum of known IKZF1 mutations and contribute to a more comprehensive understanding of CVID's genetic heterogeneity. Furthermore, this case underscores the importance of considering whole genome sequencing for comprehensive genetic diagnosis when concern for a monogenic inborn errors of immunity is high.
    Language English
    Publishing date 2024-05-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1459903-x
    ISSN 1521-7035 ; 1521-6616
    ISSN (online) 1521-7035
    ISSN 1521-6616
    DOI 10.1016/j.clim.2024.110244
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top